The treatment of benign prostatic hyperplasia: a glimpse into the future.Urol Clin North Am. 1995 May; 22(2):455-9.UC
Abstract
The treatment of BPH has changed dramatically over the last decade. Industry has recognized the potential market for BPH therapies. Urologists have accepted and embrace the development of alternative treatment strategies. The combined resources and talents of industry and academic urology will lead to exciting future advances in this field. The optimal treatment of BPH requires not only new technology but a better understanding of the pathophysiology and natural history of this disease. Urologists are presently engaged in studies to better define these fundamental aspects of the disease process. The end result of these investigative efforts will be to the advantage of patients afflicted with BPH.
Pub Type(s)
Journal Article
Language
eng
PubMed ID
7539191
Citation
Lepor, H. "The Treatment of Benign Prostatic Hyperplasia: a Glimpse Into the Future." The Urologic Clinics of North America, vol. 22, no. 2, 1995, pp. 455-9.
Lepor H. The treatment of benign prostatic hyperplasia: a glimpse into the future. Urol Clin North Am. 1995;22(2):455-9.
Lepor, H. (1995). The treatment of benign prostatic hyperplasia: a glimpse into the future. The Urologic Clinics of North America, 22(2), 455-9.
Lepor H. The Treatment of Benign Prostatic Hyperplasia: a Glimpse Into the Future. Urol Clin North Am. 1995;22(2):455-9. PubMed PMID: 7539191.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The treatment of benign prostatic hyperplasia: a glimpse into the future.
A1 - Lepor,H,
PY - 1995/5/1/pubmed
PY - 1995/5/1/medline
PY - 1995/5/1/entrez
SP - 455
EP - 9
JF - The Urologic clinics of North America
JO - Urol Clin North Am
VL - 22
IS - 2
N2 - The treatment of BPH has changed dramatically over the last decade. Industry has recognized the potential market for BPH therapies. Urologists have accepted and embrace the development of alternative treatment strategies. The combined resources and talents of industry and academic urology will lead to exciting future advances in this field. The optimal treatment of BPH requires not only new technology but a better understanding of the pathophysiology and natural history of this disease. Urologists are presently engaged in studies to better define these fundamental aspects of the disease process. The end result of these investigative efforts will be to the advantage of patients afflicted with BPH.
SN - 0094-0143
UR - https://www.unboundmedicine.com/medline/citation/7539191
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
